Status:
COMPLETED
Different Doses of Vitamin A Supplementation and Male and Female Morbidity and Mortality
Lead Sponsor:
Bandim Health Project
Conditions:
Mortality
Morbidity
Eligibility:
All Genders
6-5 years
Phase:
PHASE4
Brief Summary
We previously compared the effect on mortality of the half dose and the full dose currently recommended by WHO. Unexpectedly, the low dose was clearly better for girls, but not for boys. The girls' re...
Detailed Description
In Guinea-Bissau, a combined OPV and VAS campaign took place in November 2002. Given the uncertainty about the best dose of VAS, we examined whether the half dose compared with the full dose currently...
Eligibility Criteria
Inclusion
- Between 6 mo and 5 years of age and thus eligible for vitamin A and OPV campaign -
Exclusion
- Overt signs of vitamin A deficiency
- \-
Key Trial Info
Start Date :
November 1 2004
Trial Type :
INTERVENTIONAL
End Date :
Estimated Enrollment :
11000 Patients enrolled
Trial Details
Trial ID
NCT00168636
Start Date
November 1 2004
Last Update
November 15 2013
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Bandim Health Project, Apartado 861
Bissau, Guinea-Bissau